Search Results 641-650 of 18334 for prednisone

1. OBINUTUZUMAB in Treatment of Fibrillary Glomerulonephritis - Mayo Clinic

   Patient who are on prednisone therapy at a dose > 10 mg/day in the last 15 days. Patients who received rituximab previously with CD20 count of < 5 cells ...

2. A Study of Subcutaneous Nivolumab + Relatlimab FDC in Previously Untreated Metastatic or Unresectable Melanoma - Mayo Clinic

   In addition, participants must have been either off corticosteroids, or on a stable or decreasing dose of ≤ 10 mg daily prednisone (or equivalent) for at least ...

3. Study of Oraxol and Pembrolizumab in Subjects with Advanced Solid Tumors - Mayo Clinic

   of prednisone or its equivalent. - Vaccinated with live, attenuated vaccines within 28 days of the first dose of the study drug - Active or prior documented ...

4. A Study Of Andecaliximab In Participants With Fibrodysplasia Ossificans Progressiva (FOP) - Mayo Clinic

   Systemic corticosteroids with a prednisone equivalent of >10mg/day within 1 week of Study Day 1. If the participant requires chronic use of >10mg/day ...

5. Bendamustine Hydrochloride and Rituximab with or without Bortezomib Followed by Rituximab with or without Lenalidomide in Treating Patients with High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma - Mayo Clinic

   Prednisone or other corticosteroids used for non-lymphomatous conditions will not be considered as prior chemotherapy; A prior/recent short course (< 2 weeks) ...

6. A Phase 1 Study of Voruciclib in Subjects With B-Cell Malignancies or AML - Mayo Clinic

   corticosteroids (≤20 mg/day of prednisone or equivalent), topical, or inhaled corticosteroids 2. During study therapy, subjects may use systemic, topical ...

7. Mayo Clinic Finds Steroids May Shorten Hospital Stay for Pneumonia Patients

   ROCHESTER, Minn. — Patients with pneumonia may spend fewer days in the hospital if they are given steroids along with antibiotics and supportive care.

8. A Study of the Outcomes of Natalizumab plus Standard Steroid Treatment for High Risk Acute Graft-Versus-Host Disease - Mayo Clinic

   No prior systemic treatment for acute GVHD except for a maximum of 3 days of prednisone (or IV methylprednisolone) ≤2 mg/kg/day. Topical skin steroid ...

9. Keloid scar - Diagnosis and treatment - Mayo Clinic

   Wound care. For newer keloids, the first treatment option might be compression dressings made from stretchy fabric or other materials. · Corticosteroid cream.

10. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

    prednisone or equivalent), androgens, or androgen reducing agents, systemic beta agonists or beta blockers, and relevant herbal, or nutraceutical products ...